1. Home
  2. COCP vs GFAI Comparison

COCP vs GFAI Comparison

Compare COCP & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.07

Market Cap

14.1M

Sector

Health Care

ML Signal

HOLD

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

HOLD

Current Price

$0.35

Market Cap

15.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCP
GFAI
Founded
2006
2018
Country
United States
Singapore
Employees
N/A
1657
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.1M
15.9M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
COCP
GFAI
Price
$1.07
$0.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$4.50
AVG Volume (30 Days)
44.4K
161.1K
Earning Date
05-15-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
54.65
N/A
EPS
N/A
N/A
Revenue
$12,712,091.00
N/A
Revenue This Year
N/A
$14.12
Revenue Next Year
N/A
$10.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$0.31
52 Week High
$2.03
$1.38

Technical Indicators

Market Signals
Indicator
COCP
GFAI
Relative Strength Index (RSI) 58.44 37.63
Support Level $0.99 $0.31
Resistance Level $1.11 $0.42
Average True Range (ATR) 0.06 0.03
MACD 0.02 0.00
Stochastic Oscillator 93.14 17.54

Price Performance

Historical Comparison
COCP
GFAI

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific region. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, and Corporate and others. The majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions. Geographically, the company generates maximum revenue from Thailand.

Share on Social Networks: